System amelioration of insurance drug price kept in a muddle.

The national health insurance drug pricing policy has been deteriorated and trapped just in the impending step of the reference price system enforcement that was highly expected to save the NHI fund. Moreover, the medical community rather claimed to turn the pricing policy back to the former reported system while the drug industry insisted to keep the current actual transaction price system des...